Menogon — Research Summary
Menogon 75 IU FERRING is a pharmaceutical-grade menotropin formulation containing purified follicle stimulating hormone (FSH) and luteinising hormone (LH) extracted from human menopausal urine. This gonadotropin preparation represents a complex biological product extensively used in reproductive endocrinology research to investigate hypothalamic-pituitary-gonadal axis function. Each vial contains 75 international units of bioactive FSH and LH activity, providing researchers with a standardised hormonal tool for studying gonadotropin receptor interactions and downstream signalling cascades. The preparation’s biological origin ensures authentic hormone structure and post-translational modifications essential for accurate receptor binding studies. Research laboratories studying fertility mechanisms, ovarian physiology, and reproductive hormone pathways frequently utilise menotropin preparations for their predictable gonadotropin activity profiles.
Laboratory Applications
Research teams investigating reproductive biology examine menotropin formulations to analyse gonadotropin-induced cellular responses in primary cell cultures and tissue explants. Studies focus on FSH and LH receptor activation, cyclic adenosine monophosphate (cAMP) signalling pathways, and steroidogenesis regulation in granulosa and theca cells. Scientists at Stroid UK Shop utilise these preparations alongside other SARMs and peptides to investigate hormone-dependent tissue responses. Research applications include dose-response studies examining gonadotropin sensitivity, temporal analysis of hormone-induced gene expression changes, and comparative studies between recombinant and urinary-derived gonadotropin preparations. The complex oligosaccharide structures present in urinary menotropins provide unique research opportunities for studying glycosylation effects on hormone bioactivity. Reproductive endocrinology laboratories frequently incorporate menotropin studies when examining menotropins and other specialised compounds for comprehensive hormone interaction research.
Technical Specifications
| Product Name | Menogon 75 IU FERRING |
|---|---|
| Active Components | FSH + LH (75 IU combined activity) |
| Manufacturer | FERRING Pharmaceuticals |
| Form | Lyophilised powder for reconstitution |
| Source | Human menopausal urine (purified) |
| Storage | 2-8°C, protect from light |
| Stability | Verify with supplier documentation |
| Purity | Pharmaceutical grade (verify with supplier) |
Research Compliance
This menotropin preparation is supplied strictly for in-vitro laboratory research purposes only. Not intended for human consumption, clinical application, or therapeutic use. Researchers must possess appropriate institutional ethics approval and biosafety protocols when handling biological hormone preparations. All studies should comply with relevant research guidelines for gonadotropin handling and disposal. Purchase restricted to qualified research institutions and licensed laboratories conducting legitimate reproductive endocrinology investigations.
